J&J, Bavarian Nordic and GSK involved in upcoming Ebola vax trials; Researchers develop rheumatoid arthritis immunotherapy;

> Upcoming Ebola vaccine trials in Ghana will be led by Johnson & Johnson ($JNJ) and Bavarian Nordic in Phase I and GlaxoSmithKline ($GSK) in Phase II. Report

> Australia's University of Queensland researchers developed an immunotherapy for people with the most common form of rheumatoid arthritis. More

> Cellular Biomedicine Group ($CBMG) acquired from Blackbird Bio Finance a cancer vaccine to be used in a trial of non-small cell lung cancer. Release

> A cancer vaccine from Australia's Regenus, originally tried in dogs, will be used in 21 humans with advanced cancers who have exhausted all available treatment regimens. Report